Challenges of SNP genotyping and genetic variation

Its future role in diagnosis and treatment of cancer

Toralf Bernig, Stephen J. Chanock

Research output: Contribution to journalArticle

Abstract

Thorough annotation of common germline genetic variation in the human genome has generated a foundation for the investigation of the contribution of genetics to the etiology and pathogenesis of cancer. For many malignancies, it has become increasingly apparent that numerous alleles, with small-to-moderate effects, additively contribute to cancer susceptibility. The most common genetic variant in the genome, the single nucleotide polymorphism, is of special interest for the study of susceptibility to and protection from cancer. Similarly, intense effort has focused on genetic variants that can predict either response or toxicity to therapeutic interventions. This review discusses the challenges and prospects of genetic association studies in cancer research. On the basis of recent changes in genomics and high-throughput genotyping platforms, future genetic findings of association studies could impact clinical care and public health screening.

Original languageEnglish (US)
Pages (from-to)319-331
Number of pages13
JournalExpert Review of Molecular Diagnostics
Volume6
Issue number3
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Single Nucleotide Polymorphism
Genetic Association Studies
Neoplasms
Human Genome
Genomics
Public Health
Alleles
Genome
Research
Therapeutics

Keywords

  • Cancer susceptibility
  • Genetic association study
  • Haplotype
  • Linkage disequilibrium
  • Pharmacogenomics
  • SNP

ASJC Scopus subject areas

  • Genetics

Cite this

Challenges of SNP genotyping and genetic variation : Its future role in diagnosis and treatment of cancer. / Bernig, Toralf; Chanock, Stephen J.

In: Expert Review of Molecular Diagnostics, Vol. 6, No. 3, 2006, p. 319-331.

Research output: Contribution to journalArticle

@article{79bf2de49fda49bfa48367de84612b30,
title = "Challenges of SNP genotyping and genetic variation: Its future role in diagnosis and treatment of cancer",
abstract = "Thorough annotation of common germline genetic variation in the human genome has generated a foundation for the investigation of the contribution of genetics to the etiology and pathogenesis of cancer. For many malignancies, it has become increasingly apparent that numerous alleles, with small-to-moderate effects, additively contribute to cancer susceptibility. The most common genetic variant in the genome, the single nucleotide polymorphism, is of special interest for the study of susceptibility to and protection from cancer. Similarly, intense effort has focused on genetic variants that can predict either response or toxicity to therapeutic interventions. This review discusses the challenges and prospects of genetic association studies in cancer research. On the basis of recent changes in genomics and high-throughput genotyping platforms, future genetic findings of association studies could impact clinical care and public health screening.",
keywords = "Cancer susceptibility, Genetic association study, Haplotype, Linkage disequilibrium, Pharmacogenomics, SNP",
author = "Toralf Bernig and Chanock, {Stephen J.}",
year = "2006",
doi = "10.1586/14737159.6.3.319",
language = "English (US)",
volume = "6",
pages = "319--331",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Challenges of SNP genotyping and genetic variation

T2 - Its future role in diagnosis and treatment of cancer

AU - Bernig, Toralf

AU - Chanock, Stephen J.

PY - 2006

Y1 - 2006

N2 - Thorough annotation of common germline genetic variation in the human genome has generated a foundation for the investigation of the contribution of genetics to the etiology and pathogenesis of cancer. For many malignancies, it has become increasingly apparent that numerous alleles, with small-to-moderate effects, additively contribute to cancer susceptibility. The most common genetic variant in the genome, the single nucleotide polymorphism, is of special interest for the study of susceptibility to and protection from cancer. Similarly, intense effort has focused on genetic variants that can predict either response or toxicity to therapeutic interventions. This review discusses the challenges and prospects of genetic association studies in cancer research. On the basis of recent changes in genomics and high-throughput genotyping platforms, future genetic findings of association studies could impact clinical care and public health screening.

AB - Thorough annotation of common germline genetic variation in the human genome has generated a foundation for the investigation of the contribution of genetics to the etiology and pathogenesis of cancer. For many malignancies, it has become increasingly apparent that numerous alleles, with small-to-moderate effects, additively contribute to cancer susceptibility. The most common genetic variant in the genome, the single nucleotide polymorphism, is of special interest for the study of susceptibility to and protection from cancer. Similarly, intense effort has focused on genetic variants that can predict either response or toxicity to therapeutic interventions. This review discusses the challenges and prospects of genetic association studies in cancer research. On the basis of recent changes in genomics and high-throughput genotyping platforms, future genetic findings of association studies could impact clinical care and public health screening.

KW - Cancer susceptibility

KW - Genetic association study

KW - Haplotype

KW - Linkage disequilibrium

KW - Pharmacogenomics

KW - SNP

UR - http://www.scopus.com/inward/record.url?scp=33745951429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745951429&partnerID=8YFLogxK

U2 - 10.1586/14737159.6.3.319

DO - 10.1586/14737159.6.3.319

M3 - Article

VL - 6

SP - 319

EP - 331

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 3

ER -